Evidence map›Paper›PMID 35650448›Full record

ReviewPharmaceutical research2023

Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.

Ali Aykut Akalın, Barış Dedekargınoğlu, Sae Rome Choi, Bumsoo Han, Altug Ozcelikkale

Abstract readReview
In one paragraph

Review in Pharmaceutical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali Aykut Akalın *Department of Mechanical Engineering, Middle East Technical University, 06531, Ankara, Turkey.
Barış Dedekargınoğlu *Department of Mechanical Engineering, Middle East Technical University, 06531, Ankara, Turkey.
Sae Rome ChoiSchool of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, Indiana, 47907, USA.
Bumsoo HanSchool of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, Indiana, 47907, USA. bumsoo@purdue.edu.
Altug OzcelikkaleDepartment of Mechanical Engineering, Middle East Technical University, 06531, Ankara, Turkey. aozcelik@metu.edu.tr.ORCID http://orcid.org/0000-0002-1783-4445

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated ThrombosisU01HL143403 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FISHEL, MELISSA L., FLICK, MATTHEW J. · 2018 to 2022
$4.2M
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitorsR01CA254110 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI FISHEL, MELISSA L., HAN, BUMSOO · 2021 to 2025
$2.1M
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid ChipR61HL159948 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GILLETTE, MARTHA U, HAN, BUMSOO · 2021 to 2022
$1.7M
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid ChipR33HL159948 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GILLETTE, MARTHA U, HAN, BUMSOO · 2023 to 2025
$1.4M
National Science Foundation MCB-2134603NCI NIH HHS P30 CA023168NCI NIH HHS R01 CA254110NHLBI NIH HHS R33 HL159948NHLBI NIH HHS R61 HL159948NHLBI NIH HHS U01 HL143403NIH HHS P30 CA023168NIH HHS R01 CA254110NIH HHS R61 HL159948NIH HHS U01 HL143403Türkiye Bilimsel ve Teknolojik Araştirma Kurumu TÜBİTAK 2232 118C200
6 · The paper itself

Abstract

Computational modeling of drug delivery is becoming an indispensable tool for advancing drug development pipeline, particularly in nanomedicine where a rational design strategy is ultimately sought. While numerous in silico models have been developed that can accurately describe nanoparticle interactions with the bioenvironment within prescribed length and time scales, predictive design of these drug carriers, dosages and treatment schemes will require advanced models that can simulate transport processes across multiple length and time scales from genomic to population levels. In order to address this problem, multiscale modeling efforts that integrate existing discrete and continuum modeling strategies have recently emerged. These multiscale approaches provide a promising direction for bottom-up in silico pipelines of drug design for delivery. However, there are remaining challenges in terms of model parametrization and validation in the presence of variability, introduced by multiple levels of heterogeneities in disease state. Parametrization based on physiologically relevant in vitro data from microphysiological systems as well as widespread adoption of uncertainty quantification and sensitivity analysis will help address these challenges.

Indexed as

Drug Delivery SystemsNanoparticlesComputer SimulationDrug CarriersUncertaintyDrug Carrierscontinuum modelingdiscrete modelingnanomedicinesensitivity analysis

Identifiers

PMID35650448
PMCPMC9712595

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.